This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Chip Stocks, Duoyuan: After-Hours Trading

Expedia (EXPE - Get Report) shares advanced in late trades after the reached terms on a distribution agreement with American Airlines, a unit of AMR Corp. (AMR).

Expedia's stock was last quoted at $23.65, up 5.4%, on volume of around 87,000, according to Nasdaq.com. AMR edged up 1.1% to $6.34 with roughly 60,000 shares changing hands.

Additional terms of the agreement weren't disclosed. Expedia and American Airlines have been at odds since early January. At the heart of the dispute was the insistence of American Airlines that its flight information be accessed through a direct electronic link, rather than global distribution system technology, and the press release seemed to indicate an accommodation had been made.

Other stocks making notable moves after the bell included Cubist Pharmaceuticals (CBST), which gained more than 14% to $28.94 on volume of 1.2 million after the company settled a patent lawsuit related to its Cubicin drug for blood infections with Teva Pharmaceuticals (TEVA) and hammered out a licensing agreement; Questcor Pharmaceuticals (QCOR), which surged 18% to $17.60 on volume of around 220,000 after forecasting strong first-quarter results with sales projected at $48.6 million; and Meru Networks (MERU - Get Report), which fell 6% to $17.70 on volume of less than 10,000 after giving a disappointing revenue forecast for its first quarter because of delays in the approval of certain deals, primarily in the United States.

-- Written by Michael Baron in New York.

>To contact the writer of this article, click here: Michael Baron.

>To submit a news tip, send an email to: tips@thestreet.com
Disclosure: TheStreet's editorial policy prohibits staff editors, reporters and analysts from holding positions in any individual stocks.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
ONNN $0.00 0.00%
CBST $101.94 0.14%
QCOR $93.60 1.65%
TQNT $80.94 -1.47%
ADI $64.38 0.00%

Markets

DOW 17,730.11 -27.80 -0.16%
S&P 500 2,076.78 -0.64 -0.03%
NASDAQ 5,009.2140 -3.9090 -0.08%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs